Title | Pityriasis lichenoides-like drug reaction: A clinical histopathologic study of 10 cases. |
Publication Type | Journal Article |
Year of Publication | 2017 |
Authors | Magro C, Guo R, Nguyen GHuong, Tsang H, Momtahen S |
Journal | Dermatol Online J |
Volume | 23 |
Issue | 11 |
Date Published | 2017 Nov 15 |
ISSN | 1087-2108 |
Keywords | Adult, Aged, Aged, 80 and over, Antidepressive Agents, Diagnosis, Differential, Drug Eruptions, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lichenoid Eruptions, Male, Middle Aged, Pityriasis Lichenoides, Retrospective Studies, Skin, T-Lymphocytes |
Abstract | BACKGROUND: Lymphomatoid drug reactions can mimic endogenous T and B cell lymphoproliferative diseases. OBJECTIVES: We present a novel form of cutaneous drug reaction with features of pityriasis lichenoides (PL), a recognized form of T cell dyscrasia. METHODS: Ten cases were studied where a cutaneous eruption exhibiting semblance to PL within a few weeks to months after starting a particular drug. RESULTS: The patient cohort comprised 7 females and 3 males with the mean age of 60 years. Widely distributederythematous cutaneous lesions were present in 6 cases whereas a more localized distribution was seen in three cases. The most frequently implicated drugsassociated with the eruption were antidepressants and statins. Histologic examination showed a morphologic picture identical to PL including marked epitheliotropism of mildly atypical lymphocytes, psoriasiform epidermal hyperplasia, dyskeratosis, hemorrhage, and a thick parakeratotic scale. Therewas a significant reduction in the expression of CD7 and CD62L amid the T cells. Regression of the eruption occurred in all cases excluding one. CONCLUSION: Thefindings conform the categorization of this process as a form of T-cell dyscrasia albeit one that is reversible, dependent on the drug withdrawal. The limitationof our study includes the retrospective design of the study. |
Alternate Journal | Dermatol Online J |
PubMed ID | 29447634 |
Related Faculty:
Cynthia M. Magro, M.D.